Identification quantification and genome visualization method for integron-drug resistance gene cassette in environmental sample

A method integrating second-generation sequencing and PCR with third-generation sequencing technologies constructs an integrase gene database for high-throughput identification and quantification of integrons, addressing underestimation issues and enabling effective control of drug-resistant gene cassettes.

CN119132409AActive Publication Date: 2024-12-13EAST CHINA NORMAL UNIV

Patent Information

Application Number
CN202411163987.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-23
Publication Date
2024-12-13
Estimated Expiration
2044-08-23

AI Technical Summary

Technical Problem

Existing methods for detecting and quantifying integrons and their drug resistance gene cassettes are limited by low-throughput characterization and underestimation of integrase gene sequences, lacking high-throughput and accurate identification and quantification methods for environmental samples.

Method used

A method combining second-generation metagenomic sequencing, PCR amplification, and third-generation long-read sequencing to construct an integrase gene diversity database, using custom scripts for identification and visualization of integron-resistance gene cassettes, including database construction, PCR amplification, and long-read sequencing for genome visualization.

Benefits of technology

Enables high-throughput identification and quantification of integrons and their drug resistance gene cassettes, providing a comprehensive understanding of environmental resistance pollution and supporting targeted control of high-risk resistant pollutants.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119132409A_ABST
    Figure CN119132409A_ABST
Patent Text Reader

Abstract

The invention discloses a method for identifying, quantifying and visualizing an integron-drug-resistant gene cassette in an environmental sample. The method comprises the following steps: performing high-throughput identification, quantification and genome visualization on a movable genetic element integron based on three-generation sequencing and a drug-resistant gene mediated by the movable genetic element integron; comprising the following steps: 1) integron identification and quantification: constructing an integrase gene database by applying a'collection-screening-verification 'strategy and applying the strategy to integron identification and quantification; 2) identifying the drug-resistant gene cassette and visualizing the genome, namely obtaining DNA (Deoxyribose Nucleic Acid) by utilizing an optimized variable region gene cassette primer in combination with a PCR (Polymerase Chain Reaction) technology, sequencing by adopting PacBio three-generation full-length amplicons to obtain a long sequence of diversity of the gene cassette, and identifying the type of the drug-resistant gene cassette mediated by the integrator on the basis of a professional database; and carrying out visual representation on the integron-multi-drug-resistant gene cassette array by using a self-defined R script, and carrying out quantification based on short sequence and drug-resistant gene cassette long fragment mapping. The invention provides technical support for monitoring and controlling the development of bacterial drug resistance.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Rapid screening kit for sulfanilamide drug resistance genes and integrase genes in bacteria and primers

    CN110512009A

Cited By

  • Nucleic acid sequence database construction method, device and equipment and readable storage medium

    CN121350002A

  • Structural variation recognition method and system based on generic genome map

    CN121884945A

  • Genome identification, quantification and visualization method for drug-resistant pathogenic bacteria in environmental sample

    CN122024852A